"10.1371_journal.pone.0132011","plos one","2015-07-15T00:00:00Z","Lena Winstedt; Sofia Järnum; Emma Andersson Nordahl; Andreas Olsson; Anna Runström; Robert Bockermann; Christofer Karlsson; Johan Malmström; Gabriella Samuelsson Palmgren; Ulf Malmqvist; Lars Björck; Christian Kjellman","Hansa Medical AB, Scheelevägen 22, P.O. Box 785, SE-22007 Lund, Sweden; Department of Clinical Sciences, Lund, Lund University, SE-221 84 Lund, Sweden; Clinical Trials Unit, Skåne University Hospital, Lund, Sweden","Conceived and designed the experiments: LW SJ JM UM CKj. Performed the experiments: SJ EAN AO AR RB CKa GSP. Analyzed the data: LW SJ CKa CKj. Wrote the paper: LW SJ EAN CKa LB CKj.","have read the journals policy and the authors of this manuscript have the following competing interests: Hansa Medical AB was the formal sponsor and funder of the clinical trial. LW, SJ, EAN, AO, AR, RB, and CK are employed by Hansa Medical AB. LB is an inventor on patent applications related to IdeS and owns shares in Hansa Medical AB. The patent applications are: 1. International publication No: WO/2006/131347 Title: USE OF THE IDES PROTEINASE (FROM S. PYOGENES) FOR TREATING AUTOIMMUNE DISEASES AND GRAFT REJECTION International publication date: 14.12.2006 2. International publication No: WO/2003/051914 Title: IDES, AN IGG-DEGRADING ENZYME OF STREPTOCOCCUS PYOGENES International publication date: 26.06.2003 This does not alter our adherence to PLOS ONE policy on sharing data and materials.","2015","07","Lena Winstedt","LW",12,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
